FDA Inspection 1266366 — Jazz Pharmaceuticals Ireland Ltd

Jazz Pharmaceuticals Ireland Ltd — FEI 3010319651

The FDA completed an inspection of Jazz Pharmaceuticals Ireland Ltd on Feb 24, 2022 in Athlone. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 24, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Athlone (Ireland)

Additional Details

Mutual Recognition Agreement (MRA)